» Articles » PMID: 32918199

"Health Is on the Back Burner:" Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs

Abstract

Background: The estimated 2.2 million people who inject drugs (PWID) in the USA experience significant gaps in preventive healthcare and a high burden of infectious, psychiatric, and other chronic diseases. Many PWID rely on emergency medical services, which are costly and not designed to deliver preventive services, manage chronic conditions, or address social needs.

Objective: The objective of this study was to explore barriers and facilitators to primary care utilization from the perspectives of PWID in New England, a region highly affected by the overdose crisis.

Design: Participants completed semi-structured qualitative interviews exploring substance use and healthcare utilization patterns.

Participants: We recruited 78 PWID through community-based organizations (e.g., syringe service programs) in 16 urban and non-urban communities throughout Massachusetts and Rhode Island.

Approach: Thematic analysis identified barriers and facilitators to primary care utilization at the individual, interpersonal, and systemic levels.

Key Results: Among 78 PWID, 48 described recent primary care experiences; 33 had positive experiences and 15 described negative experiences involving discrimination or mistrust. Individual-level barriers to primary care utilization included perceived lack of need and competing priorities (e.g., avoiding opioid withdrawal, securing shelter beds). Interpersonal-level barriers included stigma and perceived low quality of care for PWID. Systemic-level barriers included difficulty navigating healthcare systems, inadequate transportation, long wait times, and frequent provider turnover. Participants with positive primary care experiences explained how appointment reminders, flexible hours, addiction medicine-trained providers, case management services, and transportation support facilitated primary care utilization and satisfaction.

Conclusions: Findings regarding the multilevel barriers and facilitators to accessing primary care among PWID identify potential targets for programmatic interventions to improve primary care utilization in this population. Based on these findings, we make recommendations for improving the engagement of PWID in primary care as a means to advance individual and public health outcomes.

Citing Articles

Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients', community organization and healthcare workers' perspectives.

Bedard K, Boisvert I, Rochette M, Racine E, Martel-Laferriere V BMC Infect Dis. 2025; 25(1):221.

PMID: 39953410 PMC: 11829365. DOI: 10.1186/s12879-025-10617-y.


Rapid initiation of antiretrovirals at a syringe services program for people with HIV who inject drugs.

Plesons M, Yang W, Sansbury G, Suarez E, Collington C, Ekowo E Ann Med. 2025; 57(1):2461670.

PMID: 39928115 PMC: 11812110. DOI: 10.1080/07853890.2025.2461670.


Is access to crisis teams associated with changes in behavioral health mortality?.

Newton H, Beetham T, Busch S Health Aff Sch. 2025; 3(1):qxaf003.

PMID: 39877431 PMC: 11772998. DOI: 10.1093/haschl/qxaf003.


The Future of HIV: Challenges in meeting the 2030 reduction goal.

Bleichrodt A, Okano J, Fung I, Chowell G, Blower S medRxiv. 2025; .

PMID: 39830275 PMC: 11741459. DOI: 10.1101/2025.01.06.25320033.


HIV Pre-exposure Prophylaxis Prescription Initiation and Maintenance Among Homeless-Experienced People Who Use Drugs.

Eger W, Shaw L, Biello K, Lopez C, Brody J, Bazzi A J Acquir Immune Defic Syndr. 2025; 98(3):234-241.

PMID: 39813325 PMC: 11854316. DOI: 10.1097/QAI.0000000000003568.


References
1.
Biancarelli D, Biello K, Childs E, Drainoni M, Salhaney P, Edeza A . Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019; 198:80-86. PMC: 6521691. DOI: 10.1016/j.drugalcdep.2019.01.037. View

2.
Binswanger I, Kral A, Bluthenthal R, Rybold D, Edlin B . High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000; 30(3):579-81. DOI: 10.1086/313703. View

3.
Perron N, Dao M, Kossovsky M, Miserez V, Chuard C, Calmy A . Reduction of missed appointments at an urban primary care clinic: a randomised controlled study. BMC Fam Pract. 2010; 11:79. PMC: 2984453. DOI: 10.1186/1471-2296-11-79. View

4.
Wade A, Doyle J, Gane E, Stedman C, Draper B, Iser D . Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject Drugs. Clin Infect Dis. 2019; 70(9):1900-1906. DOI: 10.1093/cid/ciz546. View

5.
Artenie A, Jutras-Aswad D, Roy E, Zang G, Bamvita J, Levesque A . Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement. J Viral Hepat. 2015; 22(10):792-9. DOI: 10.1111/jvh.12393. View